INTRODUCTION
For abdominal aortic aneurysms (AAAs) with a favorable morphology, endovascular repair has become the predominant treatment. 1, 2 Open surgical repair remains an option for young or fit patients with adverse anatomic features precluding a standard endovascular aneurysm repair (EVAR), 3 but these cases must be carefully selected. Treatment of complex aneurysms with endovascular procedures is a constantly evolving field, and techniques are being developed to circumvent anatomic constraints such as short or angulated necks. There is little high level evidence comparing the efficacy of standard and complex endovascular, and open surgical procedures. 4, 5 It is perceived that specialists dealing with complex aneurysms may individualize the treatments they offer from patient to patient. This might depend on the experience of the vascular specialist, the expertise of their centre and the preferences of the patient. Our objective was to assess current practice and explore potential variability in the management of complex AAA by conducting a survey among vascular specialists.
METHODS
A 10-part online questionnaire was composed using the Bristol Online Surveys tool, which is designed for academic research, educational and public sector organizations. 6 It also contained questions relating to the operating facilities in the employing hospital (whether surgeons operate in a hybrid theatre, a standard operating room or a radiology angiosuite), country of medical practice, and stage in training of the participants (whether trainee or specialist).
Data were processed and analysed using the R Statistical Package version 3.3.1.
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Fisher's exact test was used to perform univariate analysis for categorical variables, and effect sizes quantified using odds ratios with 95% confidence intervals. Multivariate logistic regression was used to assess the effect of access to a hybrid operating theatre, adjusting for the effect of country. A p-value of less than 0.05 was considered statistically significant. This study was assessed to be an evaluation of service and thus required no formal ethical approval.
RESULTS
In total, there were 238 responses from 1001 members contacted (23.8%). 61 were received from the 196 ANZSVS members (31%,), 65 from the 155 CSVS members (42%) and 112 from the 650 VSGBI members (17%). The response rates from the three societies were significantly different (p<0.001). Of the 234 responders who stated a grade, 96% were consultant specialists. 52% of responders had access to a hybrid theatre whereas the remaining 48% did not. There was no significant difference in provision of hybrid theatres between ANZSVS (54%), CSVS (55%) and VSGBI (49%).
Endovascular repair was the most commonly chosen first line management strategy In total, 35% of vascular specialists chose ongoing surveillance whilst 61% chose to intervene. The remaining 4% did not think intervention or surveillance was appropriate; this comprised 8 responders from VSGBI (7%) and 2 from ANZSVS (3% Of those choosing ongoing surveillance the median size at which to then intervene was 60 mm in all countries. The spread of treatment thresholds is shown in Figure 3 . Choice of intervention at any threshold is outlined in Figure 4 . Endovascular management was preferred by 80% of responders and open repair by the remaining 20%. When split into countries, 92% of interventions in Australia and New Zealand were endovascular compared to 83% in Great Britain and Ireland and 61% in Canada ( Figure 5 ). The most common method of endovascular repair was FEVAR (84%) followed by EVAR with endoanchors (6%). The remaining 10% were a mixture of standard or chimney EVAR or EVAS ( Figure   6 ).
CONCLUSIONS
An unfit patient with an AAA unsuitable for standard EVAR approaching threshold for treatment is a common presentation globally. We aimed to investigate potential variability in treatments offered to a typical patient such as this, assess whether treatments differ across vascular specialists from different parts of the world, and characterize any potential differences using a survey. Vascular Societies from Canada, Australia and New Zealand, and
Great Britain and Ireland were chosen to give a view of current vascular surgical practice across different countries.
There was heterogeneity in the management of the complex AAA case presented.
Most surgeons surveyed would manage the patient operatively, with 61% choosing to intervene immediately. Endovascular repair was the most common first line management strategy for those who chose to intervene.
There were interesting differences in the management of the patient between countries. VSGBI specialists were significantly more likely to continue surveillance than both ANZSVS and CSVS. Canadian specialists were significantly more likely to perform open surgery than surgeons from Great Britain and Ireland or Australia and New Zealand, and ANZSVS were significantly more likely to treat the aneurysm with endovascular repair than VSGBI and CSVS. The same patient would therefore potentially be treated differently depending on which country they presented in. The operating environment which the surgeons had access to did not significantly vary between countries, and multivariate adjustment for this factor did not significantly affect initial treatment strategy (Table 1) .
In all countries surveyed, endovascular management was the most popular choice of intervention once treatment threshold had been reached. Another influence on the specialist's decision making process that we must consider is the cost of the procedure. It has been established that patterns of reimbursement change the proportion of standard EVAR and the treatment threshold in different countries, 10 but this has not been assessed for management of complex AAA. Standard EVAR has been reported to be less cost-effective in elective cases, 11 but in systematic reviews of juxta-renal aneurysm management there is insufficient comparative data to draw any cost-effectiveness conclusions.
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A survey-based method is in itself a limitation of this study. The response rate was significantly lower from the UK and Ireland (17%), with Canada having the highest rate at 42%, followed by Australia and New Zealand at 31%. Given the differences in response rates, particularly from practitioners in the UK and Ireland, the findings cannot be held as wholly representative. Further questions, including discovering the reasons for chosen management plans and volume of work in centers were considered, but the survey was kept brief and anonymous in an attempt to increase the response rate and reduce the likelihood of 'survey fatigue'.
Other limitations included the inability of the online survey method to give a full 3D
representation of the scans and a full consultation with the patient. Responding to the survey itself was optional, so our responders may have self-selected into a group which were particularly interested in the management of complex aneurysms.
In conclusion, our main finding in the results of this survey was the heterogeneity in management of a complex AAA among specialists worldwide. This could be explained by the lack of high level evidence demonstrating benefits of one therapeutic method over another. 4 The introduction of novel endovascular techniques such as EVAS, FEVAR and chimney grafts has been relatively recent, and long-term data on outcomes are awaited. In order to make the best and safest decisions with our patients, it is important that future research is carried out to inform us of the precise risks and benefits of each treatment method.
This will be aided by the National Vascular Registry in the UK and Ireland, and counterparts from other countries. We believe that continuous monitoring of our practices and outcomes, both within individual units and internationally through audit and validated registries, and the
